Anna Sòria

机构：Departament de Salut, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Medical Research Network, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona · ORCID：0000-0001-5671-8343

发表论文 73 篇 · 总被引 438 次 · h-index 8

代表论文

• Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study (2026 · The Lancet · 被引 26)
• Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease‐Related Cirrhosis: The ABID ‐ LSM Model (2025 · Alimentary Pharmacology & Therapeutics · 被引 8)
• Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction–associated Steatotic Liver Disease in Clinical Practice (2025 · Clinical Gastroenterology and Hepatology · 被引 6)
• Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 5)
• The rate and predictors of recompensation in patients with decompensated cirrhosis due to metabolic dysfunction–associated liver disease (MASLD) (2026 · Hepatology Communications · 被引 4)
• The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD) (2026 · Expert Review of Gastroenterology & Hepatology · 被引 3)